Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study to Investigate the Safety and Activity of Aldoxorubicin Plus Gemcitabine in Subjects With Metastatic Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02235688
Recruitment Status : Completed
First Posted : September 10, 2014
Last Update Posted : June 7, 2017
Sponsor:
Information provided by (Responsible Party):
CytRx

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : January 2017
Actual Study Completion Date : January 2017